Pharmaceutical Contract Sales Outsourcing [CSO] Market (Service: Personal Promotion, Non-personal Promotion, and Others; Therapeutic Area: Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Ot

Lowest Prices Guaranteed Length Publisher Published Date SKU
from $5,795 192 Pages Transparency Market Research Pvt. Ltd. July, 2021 TNPR16765647
Lowest Prices Guaranteed
Price from $5,795
Length 192 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date July, 2021
SKU TNPR16765647

Pharmaceutical Contract Sales Outsourcing [CSO] Market (Service: Personal Promotion, Non-personal Promotion, and Others; Therapeutic Area: Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Pharmaceutical Contract Sales Outsourcing (CSO) Market – Scope of Report

TMR’s report on the pharmaceutical contract sales outsourcing (CSO) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the overall revenue of the global pharmaceutical contract sales outsourcing (CSO) market for the period of 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global pharmaceutical contract sales outsourcing (CSO) market for the forecast period of 2021–2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global pharmaceutical contract sales outsourcing (CSO) market.

Secondary research included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomena in the global pharmaceutical contract sales outsourcing (CSO) market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the pharmaceutical contract sales outsourcing (CSO) market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the pharmaceutical contract sales outsourcing (CSO) market.

The report also delves into the competitive landscape of the global pharmaceutical contract sales outsourcing (CSO) market. Key players operating in the global pharmaceutical contract sales outsourcing (CSO) market have been identified and each of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the pharmaceutical contract sales outsourcing (CSO) market profiled in this report.

Key Questions Answered in Pharmaceutical Contract Sales Outsourcing (CSO) Market Report

How does the development of pharmaceutical contract sales outsourcing (CSO) provide scope of growth in the global pharmaceutical contract sales outsourcing (CSO) market?
How alliances and partnerships between players are widening the scope of new line of opportunities for pharmaceutical contract sales outsourcing (CSO)?
What are the revenue share projections of key segments under various criteria in the pharmaceutical contract sales outsourcing (CSO) market during the forecast period?
Which segment is likely to register highest revenue by the end of the forecast period in 2031?
How is the evolving health care system in developing countries in Asia Pacific making an impact on the overall pharmaceutical contract sales outsourcing (CSO) market?
Pharmaceutical Contract Sales Outsourcing (CSO) Market – Research Objectives and Research Approach

The comprehensive report on the global pharmaceutical contract sales outsourcing (CSO) market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and health care compliances laid down by accredited agencies in the purview of line of procedure for pharmaceutical contract sales outsourcing (CSO).

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global pharmaceutical contract sales outsourcing (CSO) market in terms of service, therapeutic area, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global pharmaceutical contract sales outsourcing (CSO) market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market
4. Market Overview
4.1. Introduction
4.1.1. Market Introduction
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Healthcare Industry Overview
5.2. Impact of Sunshine Act on Contract Sales
5.3. COVID-19 Pandemics Impact on Industry (Value Chain and Short /Mid / Long Term Impact)
6. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast, by Service
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Service, 2017–2031
6.3.1. Personal Promotion
6.3.1.1. Promotional Sales Team
6.3.1.1.1. Dedicated Sales Team
6.3.1.1.2. Syndicated Sales Team
6.3.1.2. Key Account Management
6.3.1.3. Vacancy Management
6.3.2. Non-personal Promotion
6.3.2.1. Tele-detailing
6.3.2.2. Interactive E-detailing
6.3.2.3. Customer Service
6.3.2.4. Medical Science Liaisons
6.3.2.5. Patient Engagement Services
6.3.2.6. Others
6.3.3. Other Services
6.4. Market Attractiveness Analysis, by Service
7. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast, by Therapeutic Area
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Therapeutic Area, 2017–2031
7.3.1. Cardiovascular Disorders
7.3.2. Oncology
7.3.3. Metabolic Disorders
7.3.4. Neurology
7.3.5. Orthopedic Diseases
7.3.6. Infectious Diseases
7.3.7. Others
7.4. Market Attractiveness Analysis, by Therapeutic Area
8. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Country/Region
9. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Service, 2017–2031
9.2.1. Personal Promotion
9.2.1.1. Promotional Sales Team
9.2.1.1.1. Dedicated Sales Team
9.2.1.1.2. Syndicated Sales Team
9.2.1.2. Key Account Management
9.2.1.3. Vacancy Management
9.2.2. Non-personal Promotion
9.2.2.1. Tele-detailing
9.2.2.2. Interactive E-detailing
9.2.2.3. Customer Service
9.2.2.4. Medical Science Liaisons
9.2.2.5. Patient Engagement Services
9.2.2.6. Others
9.2.3. Other Services
9.3. Market Value Forecast, by Therapeutic Area, 2017–2031
9.3.1. Cardiovascular Disorders
9.3.2. Oncology
9.3.3. Metabolic Disorders
9.3.4. Neurology
9.3.5. Orthopedic Diseases
9.3.6. Infectious Diseases
9.3.7. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Service
9.5.2. By Therapeutic Area
9.5.3. By Country
10. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Service, 2017–2031
10.2.1. Personal Promotion
10.2.1.1. Promotional Sales Team
10.2.1.1.1. Dedicated Sales Team
10.2.1.1.2. Syndicated Sales Team
10.2.1.2. Key Account Management
10.2.1.3. Vacancy Management
10.2.2. Non-personal Promotion
10.2.2.1. Tele-detailing
10.2.2.2. Interactive E-detailing
10.2.2.3. Customer Service
10.2.2.4. Medical Science Liaisons
10.2.2.5. Patient Engagement Services
10.2.2.6. Others
10.2.3. Other Services
10.3. Market Value Forecast, by Therapeutic Area, 2017–2031
10.3.1. Cardiovascular Disorders
10.3.2. Oncology
10.3.3. Metabolic Disorders
10.3.4. Neurology
10.3.5. Orthopedic Diseases
10.3.6. Infectious Diseases
10.3.7. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Service
10.5.2. By Therapeutic Area
10.5.3. By Country/Sub-region
11. Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Service, 2017–2031
11.2.1. Personal Promotion
11.2.1.1. Promotional Sales Team
11.2.1.1.1. Dedicated Sales Team
11.2.1.1.2. Syndicated Sales Team
11.2.1.2. Key Account Management
11.2.1.3. Vacancy Management
11.2.2. Non-personal Promotion
11.2.2.1. Tele-detailing
11.2.2.2. Interactive E-detailing
11.2.2.3. Customer Service
11.2.2.4. Medical Science Liaisons
11.2.2.5. Patient Engagement Services
11.2.2.6. Others
11.2.3. Other Services
11.3. Market Value Forecast, by Therapeutic Area, 2017–2031
11.3.1. Cardiovascular Disorders
11.3.2. Oncology
11.3.3. Metabolic Disorders
11.3.4. Neurology
11.3.5. Orthopedic Diseases
11.3.6. Infectious Diseases
11.3.7. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Service
11.5.2. By Therapeutic Area
11.5.3. By Country/Sub-region
12. Latin America Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Service, 2017–2031
12.2.1. Personal Promotion
12.2.1.1. Promotional Sales Team
12.2.1.1.1. Dedicated Sales Team
12.2.1.1.2. Syndicated Sales Team
12.2.1.2. Key Account Management
12.2.1.3. Vacancy Management
12.2.2. Non-personal Promotion
12.2.2.1. Tele-detailing
12.2.2.2. Interactive E-detailing
12.2.2.3. Customer Service
12.2.2.4. Medical Science Liaisons
12.2.2.5. Patient Engagement Services
12.2.2.6. Others
12.2.3. Other Services
12.3. Market Value Forecast, by Therapeutic Area, 2017–2031
12.3.1. Cardiovascular Disorders
12.3.2. Oncology
12.3.3. Metabolic Disorders
12.3.4. Neurology
12.3.5. Orthopedic Diseases
12.3.6. Infectious Diseases
12.3.7. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Service
12.5.2. By Therapeutic Area
12.5.3. By Country/Sub-region
13. Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Service, 2017–2031
13.2.1. Personal Promotion
13.2.1.1. Promotional Sales Team
13.2.1.1.1. Dedicated Sales Team
13.2.1.1.2. Syndicated Sales Team
13.2.1.2. Key Account Management
13.2.1.3. Vacancy Management
13.2.2. Non-personal Promotion
13.2.2.1. Tele-detailing
13.2.2.2. Interactive E-detailing
13.2.2.3. Customer Service
13.2.2.4. Medical Science Liaisons
13.2.2.5. Patient Engagement Services
13.2.2.6. Others
13.2.3. Other Services
13.3. Market Value Forecast, by Therapeutic Area, 2017–2031
13.3.1. Cardiovascular Disorders
13.3.2. Oncology
13.3.3. Metabolic Disorders
13.3.4. Neurology
13.3.5. Orthopedic Diseases
13.3.6. Infectious Diseases
13.3.7. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Service
13.5.2. By Therapeutic Area
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by Tier and Size of companies)
14.2. Market Share Analysis/Ranking, by Company, 2020
14.3. Company Profiles
14.3.1. Ashfield (UDG Healthcare plc)
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Growth Strategies
14.3.1.3. SWOT Analysis
14.3.2. inVentiv Health, Inc. (Syneos Health)
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Growth Strategies
14.3.2.3. SWOT Analysis
14.3.3. IQVIA
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Growth Strategies
14.3.3.3. SWOT Analysis
14.3.4. Granard Pharmaceutical Sales & Marketing
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Growth Strategies
14.3.4.3. SWOT Analysis
14.3.5. Vanguard Pharma, Inc.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Growth Strategies
14.3.5.3. SWOT Analysis
14.3.6. GTS Solution
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Growth Strategies
14.3.6.3. SWOT Analysis
14.3.7. EVERSANA
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Growth Strategies
14.3.7.3. SWOT Analysis
14.3.8. MaBiCo
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Growth Strategies
14.3.8.3. SWOT Analysis
14.3.9. QFR Solutions
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Growth Strategies
14.3.9.3. SWOT Analysis
14.3.10. Pharmaforce Ireland Ltd.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Growth Strategies
14.3.10.3. SWOT Analysis
14.3.11. Sales Focus, Inc.
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Growth Strategies
14.3.11.3. SWOT Analysis
14.3.12. Amplity Health
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Growth Strategies
14.3.12.3. SWOT Analysis

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks